Hematology & Oncology
Division of Hematology and Oncology
Carroll, Robert R. , MD
Associate Professor
Robert R. Carroll, M.D., is a University of Florida physician board certified in Internal Medicine, Hematology, and Medical Oncology who has experience in the clinical treatment of breast cancer. For the past nine years, before returning to the University, he ran a private practice devoted exclusively to the medical oncology aspects of breast cancer. This practice included an extensive clinical trials effort, genetic testing for abnormalities of BrCa1 and BrCa2, management of chemotherapy and hormonal treatments, and guidance and recommendations for breast cancer prevention in women who were at high risk for developing the disease.
Training:
All higher education has been accomplished at the University of Florida. This includes undergraduate years, medical school, internship in Internal Medicine, residency in Internal Medicine, and fellowship in Hematology and Oncology. Also, before being in private practice for the past nine years, he was on the clinical faculty.
Recent Publications:
Vogel CL, Wojtukiewicz MZ, Carroll RR, Tjulanin SA, Barajas-Figueroa LJ, Wiens BL, Neumann TA, Schwartzberg LS: First and subsequent cycle use of pegfilgastrim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo controlled phase III study. J Clin Oncol 2005 Feb 20; 23(6):1178-84
Brufsky A, Harker WG, Beck JT, Carroll RR, Tan-Chiu E, Seidler C, Hohneker J, Lacerna L, Petrone S, Perez EA: Zoledronic acid inhibits adjuvant letrozole-induced bone loss in postmenopausal women with early breast cancer. J Clin Oncol 2007 Mar 1; 24(7):829-36